<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33793562</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Use of seroprevalence to guide dengue vaccination plans for older adults in a dengue non-endemic country.</ArticleTitle><Pagination><StartPage>e0009312</StartPage><MedlinePgn>e0009312</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0009312</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0009312</ELocationID><Abstract><AbstractText>A shift in dengue cases toward the adult population, accompanied by an increased risk of severe cases of dengue in the elderly, has created an important emerging issue in the past decade. To understand the level of past DENV infection among older adults after a large dengue outbreak occurred in southern Taiwan in 2015, we screened 1498 and 2603 serum samples from healthy residents aged &#x2265; 40 years in Kaohsiung City and Tainan City, respectively, to assess the seroprevalence of anti-DENV IgG in 2016. Seropositive samples were verified to exclude cross-reaction from Japanese encephalitis virus (JEV), using DENV/JEV-NS1 indirect IgG ELISA. We further identified viral serotypes and secondary DENV infections among positive samples in the two cities. The overall age-standardized seroprevalence of DENV-IgG among participants was 25.77% in Kaohsiung and 11.40% in Tainan, and the seroprevalence was significantly higher in older age groups of both cities. Although the percentages of secondary DENV infection in Kaohsiung and Tainan were very similar (43.09% and 44.76%, respectively), DENV-1 and DENV-2 spanned a wider age range in Kaohsiung, whereas DENV-2 was dominant in Tainan. As very few studies have obtained the serostatus of DENV infection in older adults and the elderly, this study highlights the need for further investigation into antibody status, as well as the safety and efficacy of dengue vaccination in these older populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Yi-Hua</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University (NTU), Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Mei-Ying</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University (NTU), Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chien</LastName><ForeName>Yu-Wen</ForeName><Initials>YW</Initials><Identifier Source="ORCID">0000-0001-5662-8751</Identifier><AffiliationInfo><Affiliation>Department of Public Health, College of Medicine, National Cheng Kung University (NCKU), Tainan, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Tzong-Shiann</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0003-2951-6679</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, National Cheng-Kung University Hospital (NCKUH), College of Medicine, NCKU, Tainan, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Hui-Ying</ForeName><Initials>HY</Initials><Identifier Source="ORCID">0000-0001-9618-4710</Identifier><AffiliationInfo><Affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University (NTU), Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chin-Rur</ForeName><Initials>CR</Initials><Identifier Source="ORCID">0000-0002-0178-7744</Identifier><AffiliationInfo><Affiliation>Institute of Immunology, College of Medicine, NTU, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Shu-Fen</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Center for Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chia-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes (NHRI), Tainan, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shu-Yu</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University (NTU), Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Pin-Wei</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University (NTU), Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Pei-Yun</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Center for Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Day-Yu</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Chao-Ying</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Health, Kaohsiung City Government, Kaohsiung, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hong-Ming</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Public Health Bureau, Tainan City Government, Tainan, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perng</LastName><ForeName>Guey-Chuen</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University (NCKU), Tainan, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ku</LastName><ForeName>Chia-Chi</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Institute of Immunology, College of Medicine, NTU, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Chwan-Chuen</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-6078-2601</Identifier><AffiliationInfo><Affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University (NTU), Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>17</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33793562</ArticleId><ArticleId IdType="pmc">PMC8075253</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0009312</ArticleId><ArticleId IdType="pii">PNTD-D-20-01334</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al.. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(6):712&#x2013;23. Epub 2016/02/15. 10.1016/S1473-3099(16)00026-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)00026-8</ArticleId><ArticleId IdType="pmc">PMC5012511</ArticleId><ArticleId IdType="pubmed">26874619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer MU, Sinka ME, Duda KA, Mylne AQ, Shearer FM, Barker CM, et al.. The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. Elife. 2015;4:e08347. Epub 2015/07/01. 10.7554/eLife.08347 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.08347</ArticleId><ArticleId IdType="pmc">PMC4493616</ArticleId><ArticleId IdType="pubmed">26126267</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultes OL, Morais MHF, Cunha M, Sobral A, Caiaffa WT. Spatial analysis of dengue incidence and Aedes aegypti ovitrap surveillance in Belo Horizonte, Brazil. Trop Med Int Health. 2020. Epub 2020/11/08. 10.1111/tmi.13521 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tmi.13521</ArticleId><ArticleId IdType="pubmed">33159826</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO International Travel and Health: Dengue. 2020. http://www.who.int/ith/diseases/dengue/en/index.html.</Citation></Reference><Reference><Citation>WHO. WHO Global Strategy for Dengue Prevention and Control 2012&#x2013;2020 2012. http://www.who.int/denguecontrol/9789241504034/en.</Citation></Reference><Reference><Citation>Redondo-Bravo L, Ruiz-Huerta C, Gomez-Barroso D, Sierra-Moros MJ, Benito A, Herrador Z. Imported dengue in Spain: a nationwide analysis with predictive time series analyses. J Travel Med. 2019;26(8). Epub 2019/10/15. 10.1093/jtm/taz072 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taz072</ArticleId><ArticleId IdType="pmc">PMC6927315</ArticleId><ArticleId IdType="pubmed">31608405</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S, Wilder-Smith A. Severe dengue in travellers: pathogenesis, risk and clinical management. J Travel Med. 2019;26(7). Epub 2019/08/20. 10.1093/jtm/taz062 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taz062</ArticleId><ArticleId IdType="pubmed">31423536</ArticleId></ArticleIdList></Reference><Reference><Citation>Masyeni S, Yohan B, Somia IKA, Myint KSA, Sasmono RT. Dengue infection in international travellers visiting Bali, Indonesia. J Travel Med. 2018;25(1). Epub 2018/08/17. 10.1093/jtm/tay061 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/tay061</ArticleId><ArticleId IdType="pmc">PMC6118167</ArticleId><ArticleId IdType="pubmed">30113689</ArticleId></ArticleIdList></Reference><Reference><Citation>Jentes ES, Lash RR, Johansson MA, Sharp TM, Henry R, Brady OJ, et al.. Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians. J Travel Med. 2016;23(6). Epub 2016/09/15. 10.1093/jtm/taw062 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taw062</ArticleId><ArticleId IdType="pmc">PMC5345513</ArticleId><ArticleId IdType="pubmed">27625400</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe EK, Leo YS, Wong JG, Thein TL, Gan VC, Lee LK, et al.. Challenges in dengue fever in the elderly: atypical presentation and risk of severe dengue and hospital-acquired infection [corrected]. PLoS Negl Trop Dis. 2014;8(4):e2777. Epub 2014/04/05. 10.1371/journal.pntd.0002777 not alter our adherence to all PLOS policies on sharing data and materials.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002777</ArticleId><ArticleId IdType="pmc">PMC3974675</ArticleId><ArticleId IdType="pubmed">24699282</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia R, Dash AP, Sunyoto T. Changing epidemiology of dengue in South-East Asia. WHO South East Asia J Public Health. 2013;2(1):23&#x2013;7. Epub 2013/01/01. 10.4103/2224-3151.115830 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2224-3151.115830</ArticleId><ArticleId IdType="pubmed">28612819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A, Ooi EE, Horstick O, Wills B. Dengue. Lancet. 2019;393(10169):350&#x2013;63. Epub 2019/01/31. 10.1016/S0140-6736(18)32560-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32560-1</ArticleId><ArticleId IdType="pubmed">30696575</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WJ. Dengue outbreaks and the geographic distribution of dengue vectors in Taiwan: A 20-year epidemiological analysis. Biomed J. 2018;41(5):283&#x2013;9. Epub 2018/12/26. 10.1016/j.bj.2018.06.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2018.06.002</ArticleId><ArticleId IdType="pmc">PMC6306330</ArticleId><ArticleId IdType="pubmed">30580791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CC, Huang YH, Shu PY, Wu HS, Lin YS, Yeh TM, et al.. Characteristic of dengue disease in Taiwan: 2002&#x2013;2007. Am J Trop Med Hyg. 2010;82(4):731&#x2013;9. Epub 2010/03/30. 10.4269/ajtmh.2010.09-0549 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2010.09-0549</ArticleId><ArticleId IdType="pmc">PMC2844571</ArticleId><ArticleId IdType="pubmed">20348527</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YC. [Epidemic dengue 2 on Liouchyou Shiang, Pingtung County in 1981]. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1986;19(3):203&#x2013;11. Epub 1986/08/01. .</Citation><ArticleIdList><ArticleId IdType="pubmed">3816365</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SF, Huang JH, Chen LK, Su CL, Liao TL, Chien LJ, et al.. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000. J Microbiol Immunol Infect. 2008;41(5):377&#x2013;85. Epub 2009/01/06. .</Citation><ArticleIdList><ArticleId IdType="pubmed">19122918</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuen King C, Chang Wu Y, Chao D-Y, Lin T-H, Chow L, Wang H-T, et al.. Major Epidemics of Dengue in Taiwan in 1981&#x2013;2000: Related to Intensive Virus Activities in Asia. 2000.</Citation></Reference><Reference><Citation>Shu PY, Chien LJ, Chang SF, Su CL, Kuo YC, Liao TL, et al.. Fever screening at airports and imported dengue. Emerg Infect Dis. 2005;11(3):460&#x2013;2. Epub 2005/03/11. 10.3201/eid1103.040420 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1103.040420</ArticleId><ArticleId IdType="pmc">PMC3298237</ArticleId><ArticleId IdType="pubmed">15757566</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang CS, Fang CT, Liu CM, Wen TH, Tsai KH, King CC. The role of imported cases and favorable meteorological conditions in the onset of dengue epidemics. PLoS Negl Trop Dis. 2010;4(8):e775. Epub 2010/08/07. 10.1371/journal.pntd.0000775 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000775</ArticleId><ArticleId IdType="pmc">PMC2914757</ArticleId><ArticleId IdType="pubmed">20689820</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SF, Huang JH, Shu PY. Characteristics of dengue epidemics in Taiwan. J Formos Med Assoc. 2012;111(6):297&#x2013;9. Epub 2012/07/04. 10.1016/j.jfma.2011.12.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2011.12.001</ArticleId><ArticleId IdType="pubmed">22748618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu JC, Hsieh CL, Lu CY. Trend and geographic analysis of the prevalence of dengue in Taiwan, 2010&#x2013;2015. Int J Infect Dis. 2017;54:43&#x2013;9. Epub 2016/11/21. 10.1016/j.ijid.2016.11.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2016.11.008</ArticleId><ArticleId IdType="pubmed">27865829</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CC, Lee IK, Su MC, Lin HI, Huang YC, Liu SF, et al.. Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002. Trans R Soc Trop Med Hyg. 2009;103(9):871&#x2013;7. Epub 2009/06/09. 10.1016/j.trstmh.2009.04.024 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trstmh.2009.04.024</ArticleId><ArticleId IdType="pubmed">19500813</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CH, Schi&#xf8;ler KL, Jepsen MR, Ho CK, Li SH, Konradsen F. Dengue outbreaks in high-income area, Kaohsiung City, Taiwan, 2003&#x2013;2009. Emerg Infect Dis. 2012;18(10):1603&#x2013;11. Epub 2012/09/29. 10.3201/eid1810.111929 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1810.111929</ArticleId><ArticleId IdType="pmc">PMC3471615</ArticleId><ArticleId IdType="pubmed">23017369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo HJ, Lee IK, Liu JW. Analyses of clinical and laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: Emphasizing risk of severe dengue in the elderly. J Microbiol Immunol Infect. 2018;51(6):740&#x2013;8. Epub 2017/07/25. 10.1016/j.jmii.2016.08.024 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2016.08.024</ArticleId><ArticleId IdType="pubmed">28734676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Thein TL, Ng Y, Boudville IC, Chia PY, Lee VJM, et al.. A 15-year review of dengue hospitalizations in Singapore: Reducing admissions without adverse consequences, 2003 to 2017. PLoS Negl Trop Dis. 2019;13(5):e0007389. Epub 2019/05/16. 10.1371/journal.pntd.0007389 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007389</ArticleId><ArticleId IdType="pmc">PMC6519799</ArticleId><ArticleId IdType="pubmed">31091272</ArticleId></ArticleIdList></Reference><Reference><Citation>Woon YL, Hor CP, Hussin N, Zakaria A, Goh PP, Cheah WK. A Two-Year Review on Epidemiology and Clinical Characteristics of Dengue Deaths in Malaysia, 2013&#x2013;2014. PLoS Negl Trop Dis. 2016;10(5):e0004575. Epub 2016/05/21. 10.1371/journal.pntd.0004575 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004575</ArticleId><ArticleId IdType="pmc">PMC4874788</ArticleId><ArticleId IdType="pubmed">27203726</ArticleId></ArticleIdList></Reference><Reference><Citation>Huy BV, Hoa LNM, Thuy DT, Van Kinh N, Ngan TTD, Duyet LV, et al.. Epidemiological and Clinical Features of Dengue Infection in Adults in the 2017 Outbreak in Vietnam. Biomed Res Int. 2019;2019:3085827. Epub 2019/12/10. 10.1155/2019/3085827 publication of this paper.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/3085827</ArticleId><ArticleId IdType="pmc">PMC6877935</ArticleId><ArticleId IdType="pubmed">31815129</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Dengue vaccine: WHO position paper, September 2018&#x2014;Recommendations. Vaccine. 2019;37(35):4848&#x2013;9. Epub 2018/11/15. 10.1016/j.vaccine.2018.09.063 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.09.063</ArticleId><ArticleId IdType="pubmed">30424888</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S. Recent advances in understanding dengue. F1000Res. 2019;8. Epub 2019/08/27. 10.12688/f1000research.19197.1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.19197.1</ArticleId><ArticleId IdType="pmc">PMC6676504</ArticleId><ArticleId IdType="pubmed">31448083</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo KM, Khalid B, Ching SM, Chee HY. Meta-Analysis of Dengue Severity during Infection by Different Dengue Virus Serotypes in Primary and Secondary Infections. PLoS One. 2016;11(5):e0154760. Epub 2016/05/24. 10.1371/journal.pone.0154760 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0154760</ArticleId><ArticleId IdType="pmc">PMC4877104</ArticleId><ArticleId IdType="pubmed">27213782</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, et al.. Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with Dengue fever and Dengue hemorrhagic fever. J Med Virol. 2000;62(2):224&#x2013;32. Epub 2000/09/26. 10.1002/1096-9071(200010)62:2&amp;lt;224::aid-jmv14&amp;gt;3.0.co;2-c .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(200010)62:2&amp;lt;224::aid-jmv14&amp;gt;3.0.co;2-c</ArticleId><ArticleId IdType="pubmed">11002252</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, et al.. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diagn Lab Immunol. 2003;10(4):622&#x2013;30. Epub 2003/07/11. 10.1128/cdli.10.4.622-630.2003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cdli.10.4.622-630.2003</ArticleId><ArticleId IdType="pmc">PMC164246</ArticleId><ArticleId IdType="pubmed">12853395</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, et al.. Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralization test. J Clin Microbiol. 2002;40(5):1840&#x2013;4. Epub 2002/05/01. 10.1128/jcm.40.5.1840-1844.2002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.40.5.1840-1844.2002</ArticleId><ArticleId IdType="pmc">PMC130672</ArticleId><ArticleId IdType="pubmed">11980973</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai SC, Huang YY, Shu PY, Chang SF, Hsieh PS, Wey JJ, et al.. Development of an Enzyme-Linked Immunosorbent Assay for Rapid Detection of Dengue Virus (DENV) NS1 and Differentiation of DENV Serotypes during Early Infection. J Clin Microbiol. 2019;57(7). Epub 2019/04/12. 10.1128/JCM.00221-19 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00221-19</ArticleId><ArticleId IdType="pmc">PMC6595446</ArticleId><ArticleId IdType="pubmed">30971466</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ltgen K, Rose N, Ruggieri A, Warryn L, Scherr N, Pinho-Nascimento CA, et al.. Development of Dengue Virus Serotype-Specific NS1 Capture Assays for the Rapid and Highly Sensitive Identification of the Infecting Serotype in Human Sera. J Immunol. 2018;200(11):3857&#x2013;66. Epub 2018/04/18. 10.4049/jimmunol.1701790 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1701790</ArticleId><ArticleId IdType="pubmed">29661824</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K, Huang CH, Lee IK, Lu PL, Lin CY, Chen TC, et al.. Differences in Mortality and Clinical Manifestations of Dengue Hemorrhagic Fever in Taiwan in Different Years: A Comparison for Cases in 2014 and 2015 Epidemics. Am J Trop Med Hyg. 2017;97(2):361&#x2013;8. Epub 2017/07/20. 10.4269/ajtmh.16-1018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.16-1018</ArticleId><ArticleId IdType="pmc">PMC5544090</ArticleId><ArticleId IdType="pubmed">28722609</ArticleId></ArticleIdList></Reference><Reference><Citation>Taiwan National Infectious Disease Statistics System-Japanese Encephalitis [Internet]. 2020. https://nidss.cdc.gov.tw/en/nndss/disease?id=0620.</Citation></Reference><Reference><Citation>Bureau of Civil Affairs, Tainan City Government. https://bca.tainan.gov.tw/.</Citation></Reference><Reference><Citation>Bureau of Civil Affairs, Kaohsiung City Government. https://cabueng.kcg.gov.tw/.</Citation></Reference><Reference><Citation>Focus Diagnostics C, CA, USA. Dengue Virus Serology Testing. https://www.focusdx.com/pdfs/brochures/DXDENI0511_Dengue_Virus_Serology.pdf.</Citation></Reference><Reference><Citation>Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, et al.. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination. Vaccine. 2001;19(13&#x2013;14):1753&#x2013;63. Epub 2001/02/13. 10.1016/s0264-410x(00)00391-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0264-410x(00)00391-1</ArticleId><ArticleId IdType="pubmed">11166901</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LK, Liao CL, Lin CG, Lai SC, Liu CI, Ma SH, et al.. Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells. Virology. 1996;217(1):220&#x2013;9. Epub 1996/03/01. 10.1006/viro.1996.0109 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1996.0109</ArticleId><ArticleId IdType="pubmed">8599206</ArticleId></ArticleIdList></Reference><Reference><Citation>QGIS.org. QGIS Geographic Information System Open Source Geospatial Foundation Project 2020. http://qgis.org.</Citation></Reference><Reference><Citation>Yen PS, Failloux AB. A Review: Wolbachia-Based Population Replacement for Mosquito Control Shares Common Points with Genetically Modified Control Approaches. Pathogens. 2020;9(5). Epub 2020/05/28. 10.3390/pathogens9050404 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9050404</ArticleId><ArticleId IdType="pmc">PMC7281599</ArticleId><ArticleId IdType="pubmed">32456036</ArticleId></ArticleIdList></Reference><Reference><Citation>Han GS, Gregory CJ, Biggerstaff BJ, Horiuchi K, Perez-Guerra C, Soto-Gomez E, et al.. Effect of a Dengue Clinical Case Management Course on Physician Practices in Puerto Rico. Clinical Infectious Diseases. 2016;63(10):1297&#x2013;303. 10.1093/cid/ciw511</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw511</ArticleId><ArticleId IdType="pmc">PMC5086272</ArticleId><ArticleId IdType="pubmed">27506689</ArticleId></ArticleIdList></Reference><Reference><Citation>Limkittikul K, Brett J, L&#x2019;Azou M. Epidemiological trends of dengue disease in Thailand (2000&#x2013;2011): a systematic literature review. PLoS Negl Trop Dis. 2014;8(11):e3241. Epub 2014/11/07. 10.1371/journal.pntd.0003241 Ltd and ML is employed by Sanofi Pasteur. This does not alter our adherence to all PLoS policies on sharing data and materials.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003241</ArticleId><ArticleId IdType="pmc">PMC4222696</ArticleId><ArticleId IdType="pubmed">25375766</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo L, Roque VG, Brett J, Dizon R, L&#x2019;Azou M. Epidemiology of dengue disease in the Philippines (2000&#x2013;2011): a systematic literature review. PLoS Negl Trop Dis. 2014;8(11):e3027. Epub 2014/11/07. 10.1371/journal.pntd.0003027 received financial reimbursement from Pfizer to attend national and international congresses and lecture fees for attending a speakers bureau, and has acted as a consultant for Pfizer without financial reimbursement. VGR has no conflicts of interest to declare. This does not alter our adherence to all PLoS policies on sharing data and materials.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003027</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan CY, Liu WL, Su MP, Chang TP, Ho HP, Shu PY, et al.. Epidemiological analysis of the Kaohsiung city strategy for dengue fever quarantine and epidemic prevention. BMC Infect Dis. 2020;20(1):347. Epub 2020/05/18. 10.1186/s12879-020-4942-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-4942-y</ArticleId><ArticleId IdType="pmc">PMC7226716</ArticleId><ArticleId IdType="pubmed">32414340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kan CC, Lee PF, Wen TH, Chao DY, Wu MH, Lin NH, et al.. Two clustering diffusion patterns identified from the 2001&#x2013;2003 dengue epidemic, Kaohsiung, Taiwan. Am J Trop Med Hyg. 2008;79(3):344&#x2013;52. Epub 2008/09/12. .</Citation><ArticleIdList><ArticleId IdType="pubmed">18784225</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien YW, Huang HM, Ho TC, Tseng FC, Ko NY, Ko WC, et al.. Seroepidemiology of dengue virus infection among adults during the ending phase of a severe dengue epidemic in southern Taiwan, 2015. BMC Infect Dis. 2019;19(1):338. Epub 2019/04/25. 10.1186/s12879-019-3946-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-3946-y</ArticleId><ArticleId IdType="pmc">PMC6480438</ArticleId><ArticleId IdType="pubmed">31014263</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai JJ, Liu CK, Tsai WY, Liu LT, Tyson J, Tsai CY, et al.. Seroprevalence of dengue virus in two districts of Kaohsiung City after the largest dengue outbreak in Taiwan since World War II. PLoS Negl Trop Dis. 2018;12(10):e0006879. Epub 2018/10/26. 10.1371/journal.pntd.0006879 following competing interests: The DENV detect IgG ELISA kits were kindly provided by Dr. Syamal Raychaudhuri at InBios International, Inc. Seattle.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0006879</ArticleId><ArticleId IdType="pmc">PMC6218099</ArticleId><ArticleId IdType="pubmed">30356316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Cutter J, James L, Goh KT. Seroepidemiology of dengue virus infection in the adult population in tropical Singapore. Epidemiol Infect. 2015;143(8):1585&#x2013;93. Epub 2014/09/24. 10.1017/S0950268814002507 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268814002507</ArticleId><ArticleId IdType="pubmed">25245094</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhanoa A, Hassan SS, Jahan NK, Reidpath DD, Fatt QK, Ahmad MP, et al.. Seroprevalence of dengue among healthy adults in a rural community in Southern Malaysia: a pilot study. Infect Dis Poverty. 2018;7(1):1. Epub 2018/01/18. 10.1186/s40249-017-0384-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-017-0384-1</ArticleId><ArticleId IdType="pmc">PMC5769361</ArticleId><ArticleId IdType="pubmed">29335021</ArticleId></ArticleIdList></Reference><Reference><Citation>Vongpunsawad S, Intharasongkroh D, Thongmee T, Poovorawan Y. Seroprevalence of antibodies to dengue and chikungunya viruses in Thailand. PLoS One. 2017;12(6):e0180560. Epub 2017/07/01. 10.1371/journal.pone.0180560 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0180560</ArticleId><ArticleId IdType="pmc">PMC5491253</ArticleId><ArticleId IdType="pubmed">28662144</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaya-Larios IY, Mart&#xed;nez-Vega RA, Mayer SV, Galeana-Hern&#xe1;ndez M, Comas-Garc&#xed;a A, Sep&#xfa;lveda-Salinas KJ, et al.. Seroprevalence of neutralizing antibodies against dengue virus in two localities in the state of Morelos, Mexico. Am J Trop Med Hyg. 2014;91(5):1057&#x2013;65. Epub 2014/10/09. 10.4269/ajtmh.14-0145 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.14-0145</ArticleId><ArticleId IdType="pmc">PMC4228874</ArticleId><ArticleId IdType="pubmed">25294613</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes E, Fuentes M, Alarc&#xf3;n M, Palomo I. Immune System Dysfunction in the Elderly. An Acad Bras Cienc. 2017;89(1):285&#x2013;99. Epub 2017/04/20. 10.1590/0001-3765201720160487 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0001-3765201720160487</ArticleId><ArticleId IdType="pubmed">28423084</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadighi Akha AA. Aging and the immune system: An overview. J Immunol Methods. 2018;463:21&#x2013;6. Epub 2018/08/17. 10.1016/j.jim.2018.08.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2018.08.005</ArticleId><ArticleId IdType="pubmed">30114401</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancro MP, Hao Y, Scholz JL, Riley RL, Frasca D, Dunn-Walters DK, et al.. B cells and aging: molecules and mechanisms. Trends Immunol. 2009;30(7):313&#x2013;8. Epub 2009/06/23. 10.1016/j.it.2009.04.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2009.04.005</ArticleId><ArticleId IdType="pmc">PMC2766868</ArticleId><ArticleId IdType="pubmed">19540810</ArticleId></ArticleIdList></Reference><Reference><Citation>Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41 Suppl 7:S504&#x2013;12. Epub 2005/10/21. 10.1086/432007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/432007</ArticleId><ArticleId IdType="pubmed">16237654</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013;158(7):1445&#x2013;59. Epub 2013/03/09. 10.1007/s00705-013-1645-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-013-1645-3</ArticleId><ArticleId IdType="pubmed">23471635</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine. 2017;35(47):6355&#x2013;8. Epub 2017/10/17. 10.1016/j.vaccine.2017.09.089 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.09.089</ArticleId><ArticleId IdType="pubmed">29029938</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A, Smith PG, Luo R, Kelly-Cirino C, Curry D, Larson H, et al.. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. Vaccine. 2019;37(36):5137&#x2013;46. Epub 2019/08/05. 10.1016/j.vaccine.2019.07.016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.07.016</ArticleId><ArticleId IdType="pubmed">31377079</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeting SPV. Dengvaxia Tetravalent, Live-Attenuated Viral Vaccine against Dengue Serotypes 1, 2, 3 and 4 2019.</Citation></Reference><Reference><Citation>Wahala WM, Kraus AA, Haymore LB, Accavitti-Loper MA, de Silva AM. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology. 2009;392(1):103&#x2013;13. Epub 2009/07/28. 10.1016/j.virol.2009.06.037 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.06.037</ArticleId><ArticleId IdType="pmc">PMC2746956</ArticleId><ArticleId IdType="pubmed">19631955</ArticleId></ArticleIdList></Reference><Reference><Citation>Roehrig JT, Hombach J, Barrett AD. Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. Viral Immunol. 2008;21(2):123&#x2013;32. Epub 2008/05/15. 10.1089/vim.2008.0007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2008.0007</ArticleId><ArticleId IdType="pubmed">18476771</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, et al.. Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy. N Engl J Med. 2018;379(4):327&#x2013;40. Epub 2018/06/14. 10.1056/NEJMoa1800820 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1800820</ArticleId><ArticleId IdType="pubmed">29897841</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, et al.. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol. 1984;120(5):653&#x2013;69. Epub 1984/11/01. 10.1093/oxfordjournals.aje.a113932 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a113932</ArticleId><ArticleId IdType="pubmed">6496446</ArticleId></ArticleIdList></Reference><Reference><Citation>Thein S, Aung MM, Shwe TN, Aye M, Zaw A, Aye K, et al.. Risk factors in dengue shock syndrome. Am J Trop Med Hyg. 1997;56(5):566&#x2013;72. Epub 1997/05/01. 10.4269/ajtmh.1997.56.566 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1997.56.566</ArticleId><ArticleId IdType="pubmed">9180609</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Papaevangelou G. Transmission of dengue 1 and 2 viruses in Greece in 1928. Am J Trop Med Hyg. 1980;29(4):635&#x2013;7. Epub 1980/07/01. 10.4269/ajtmh.1980.29.635 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1980.29.635</ArticleId><ArticleId IdType="pubmed">6996504</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzm&#xe1;n MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg. 1990;42(2):179&#x2013;84. Epub 1990/02/01. 10.4269/ajtmh.1990.42.179 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1990.42.179</ArticleId><ArticleId IdType="pubmed">2316788</ArticleId></ArticleIdList></Reference><Reference><Citation>Olkowski S, Forshey BM, Morrison AC, Rocha C, Vilcarromero S, Halsey ES, et al.. Reduced risk of disease during postsecondary dengue virus infections. J Infect Dis. 2013;208(6):1026&#x2013;33. Epub 2013/06/19. 10.1093/infdis/jit273 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit273</ArticleId><ArticleId IdType="pmc">PMC3749012</ArticleId><ArticleId IdType="pubmed">23776195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CL, Chang HL, Lin CY, Chen KT. Seasonal Patterns of Japanese Encephalitis and Associated Meteorological Factors in Taiwan. Int J Environ Res Public Health. 2017;14(11). Epub 2017/11/08. 10.3390/ijerph14111317 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph14111317</ArticleId><ArticleId IdType="pmc">PMC5707956</ArticleId><ArticleId IdType="pubmed">29109371</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J-J. Disease control of Japanese Encephalitis: 2018 Kaohsiung strategies (In Chinese)2018.</Citation></Reference><Reference><Citation>Chen WJ, Chen SL, Chien LJ, Chen CC, King CC, Harn MR, et al.. Silent transmission of the dengue virus in southern Taiwan. Am J Trop Med Hyg. 1996;55(1):12&#x2013;6. Epub 1996/07/01. 10.4269/ajtmh.1996.55.12 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1996.55.12</ArticleId><ArticleId IdType="pubmed">8702015</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao DY, Lin TH, Hwang KP, Huang JH, Liu CC, King CC. 1998 dengue hemorrhagic fever epidemic in Taiwan. Emerg Infect Dis. 2004;10(3):552&#x2013;4. Epub 2004/05/01. 10.3201/eid1003.020518 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1003.020518</ArticleId><ArticleId IdType="pmc">PMC3322789</ArticleId><ArticleId IdType="pubmed">15116715</ArticleId></ArticleIdList></Reference><Reference><Citation>Taiwan National Infectious Disease Statistics System-ZIKA virus [Internet]. 2020. https://nidss.cdc.gov.tw/nndss/disease?id=ZIKAV.</Citation></Reference><Reference><Citation>Chien YW, Ho TC, Huang PW, Ko NY, Ko WC, Perng GC. Low seroprevalence of Zika virus infection among adults in Southern Taiwan. BMC Infect Dis. 2019;19(1):884. Epub 2019/10/28. 10.1186/s12879-019-4491-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-4491-4</ArticleId><ArticleId IdType="pmc">PMC6813068</ArticleId><ArticleId IdType="pubmed">31646973</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan SJ, Carlson CJ, Mordecai EA, Johnson LR. Global expansion and redistribution of Aedes-borne virus transmission risk with climate change. PLoS Negl Trop Dis. 2019;13(3):e0007213. Epub 2019/03/29. 10.1371/journal.pntd.0007213 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007213</ArticleId><ArticleId IdType="pmc">PMC6438455</ArticleId><ArticleId IdType="pubmed">30921321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratnam I, Leder K, Black J, Torresi J. Dengue fever and international travel. J Travel Med. 2013;20(6):384&#x2013;93. Epub 2013/10/30. 10.1111/jtm.12052 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jtm.12052</ArticleId><ArticleId IdType="pubmed">24165383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ching-Chuan L, Kao-Jean H, Mei-Chih H, Lin JJ, Wang SM, Jen-Jou L, et al.. High Case-Fatality Rate of Adults With Dengue Hemorrhagic Fever During An Outbreak In Non-Endemic Taiwan: Risk Factors For Dengue-Infected Elders. American Journal of Infectious Diseases. 2008;4(1). 10.3844/ajidsp.2008.10.17</Citation><ArticleIdList><ArticleId IdType="doi">10.3844/ajidsp.2008.10.17</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohd-Zaki AH, Brett J, Ismail E, L&#x2019;Azou M. Epidemiology of dengue disease in Malaysia (2000&#x2013;2012): a systematic literature review. PLoS Negl Trop Dis. 2014;8(11):e3159. Epub 2014/11/07. 10.1371/journal.pntd.0003159 declare. This does not alter our adherence to all PLOS policies on sharing data and materials.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003159</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Chareonsook O, Foy HM, Teeraratkul A, Silarug N. Changing epidemiology of dengue hemorrhagic fever in Thailand. Epidemiol Infect. 1999;122(1):161&#x2013;6. Epub 1999/03/31. 10.1017/s0950268898001617 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0950268898001617</ArticleId><ArticleId IdType="pmc">PMC2809602</ArticleId><ArticleId IdType="pubmed">10098800</ArticleId></ArticleIdList></Reference><Reference><Citation>Han GS, Gregory CJ, Biggerstaff BJ, Horiuchi K, Perez-Guerra C, Soto-Gomez E, et al.. Effect of a Dengue Clinical Case Management Course on Physician Practices in Puerto Rico. Clin Infect Dis. 2016;63(10):1297&#x2013;303. Epub 2016/10/30. 10.1093/cid/ciw511 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw511</ArticleId><ArticleId IdType="pmc">PMC5086272</ArticleId><ArticleId IdType="pubmed">27506689</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller DA, Young PR. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 2013;98(2):192&#x2013;208. Epub 2013/03/26. 10.1016/j.antiviral.2013.03.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.03.008</ArticleId><ArticleId IdType="pubmed">23523765</ArticleId></ArticleIdList></Reference><Reference><Citation>Watterson D, Modhiran N, Young PR. The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design. Antiviral Res. 2016;130:7&#x2013;18. Epub 2016/03/06. 10.1016/j.antiviral.2016.02.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.02.014</ArticleId><ArticleId IdType="pubmed">26944216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Kim HY, Chong CK, Song HO. Development and clinical evaluation of a highly accurate dengue NS1 rapid test: from the preparation of a soluble NS1 antigen to the construction of an RDT. Diagn Microbiol Infect Dis. 2015;82(2):128&#x2013;34. Epub 2015/04/01. 10.1016/j.diagmicrobio.2015.03.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2015.03.009</ArticleId><ArticleId IdType="pubmed">25824725</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CR, King CC, Liu LD, Ku CC. FluConvert and IniFlu: a suite of integrated software to identify novel signatures of emerging influenza viruses with increasing risk. BMC Bioinformatics. 2020;21(1):316. Epub 2020/07/20. 10.1186/s12859-020-03650-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-020-03650-y</ArticleId><ArticleId IdType="pmc">PMC7368604</ArticleId><ArticleId IdType="pubmed">32682392</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickett BE, Sadat EL, Zhang Y, Noronha JM, Squires RB, Hunt V, et al.. ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res. 2012;40(Database issue):D593&#x2013;8. Epub 2011/10/19. 10.1093/nar/gkr859 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr859</ArticleId><ArticleId IdType="pmc">PMC3245011</ArticleId><ArticleId IdType="pubmed">22006842</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasner DR, Puerta-Guardo H, Beatty PR, Harris E. The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis. Annu Rev Virol. 2018;5(1):227&#x2013;53. Epub 2018/07/26. 10.1146/annurev-virology-101416-041848 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-101416-041848</ArticleId><ArticleId IdType="pmc">PMC6311996</ArticleId><ArticleId IdType="pubmed">30044715</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YC, Wang SY, Lin YS, Chen HR, Yeh TM. Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection. J Biomed Sci. 2013;20(1):42. Epub 2013/06/29. 10.1186/1423-0127-20-42 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-42</ArticleId><ArticleId IdType="pmc">PMC3704815</ArticleId><ArticleId IdType="pubmed">23806052</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HR, Lai YC, Yeh TM. Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate. J Biomed Sci. 2018;25(1):58. Epub 2018/07/25. 10.1186/s12929-018-0462-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-018-0462-0</ArticleId><ArticleId IdType="pmc">PMC6057007</ArticleId><ArticleId IdType="pubmed">30037331</ArticleId></ArticleIdList></Reference><Reference><Citation>God&#xf3;i IP, Lemos LL, de Ara&#xfa;jo VE, Bonoto BC, Godman B, Guerra J&#xfa;nior AA. CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety. J Comp Eff Res. 2017;6(2):165&#x2013;80. Epub 2017/01/14. 10.2217/cer-2016-0045 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/cer-2016-0045</ArticleId><ArticleId IdType="pubmed">28084784</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>